Literature DB >> 22307391

Secondary fracture prevention.

Robert A Adler1.   

Abstract

Osteoporosis causes no symptoms until there is a fracture. Although screening for osteoporosis is recommended for some populations, patients may present with a fragility fracture. Such patients are at high risk for subsequent fractures. Despite this high risk and the presence of generally safe and effective osteoporosis therapy, only a minority of low trauma fracture patients have evaluation and treatment of underlying osteoporosis. A brief summary of the evaluation and medical treatment of the post-fracture patient is provided. Several institutions, integrated health systems, and countries have instituted programs to identify, evaluate, and treat fragility fracture patients. Such programs have had variable success. This article describes some of the programs that work, their cost-effectiveness, and the applicability to the generally non-integrated US health care system. It is clear that better management of the post-fracture patient (and other high-risk patients) will lead to fewer fractures, decreased morbidity and mortality, and long-term cost savings.

Entities:  

Mesh:

Year:  2012        PMID: 22307391     DOI: 10.1007/s11914-011-0090-z

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  36 in total

1.  Placebo-controlled trials in osteoporosis--proceeding with caution.

Authors:  Clifford J Rosen; Sundeep Khosla
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

2.  Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture.

Authors:  Lee A Jennings; Andrew D Auerbach; Judith Maselli; Penelope S Pekow; Peter K Lindenauer; Sei J Lee
Journal:  J Am Geriatr Soc       Date:  2010-04       Impact factor: 5.562

3.  The inpatient consultation approach to osteoporosis treatment in patients with a fracture. Is automatic consultation needed?

Authors:  Elizabeth A Streeten; Asif Mohamed; Amish Gandhi; Denise Orwig; Paul Sack; Robert Sterling; Vincent D Pellegrini
Journal:  J Bone Joint Surg Am       Date:  2006-09       Impact factor: 5.284

4.  It is time for everyone to own the bone.

Authors:  Andrew D Bunta
Journal:  Osteoporos Int       Date:  2011-08-17       Impact factor: 4.507

5.  Perspectives on pre-fracture intervention strategies: the Geisinger Health System Osteoporosis Program.

Authors:  Eric D Newman
Journal:  Osteoporos Int       Date:  2011-08-17       Impact factor: 4.507

6.  Osteoporosis in men: the value of laboratory testing.

Authors:  C S Ryan; V I Petkov; R A Adler
Journal:  Osteoporos Int       Date:  2010-10-09       Impact factor: 4.507

7.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

8.  Risedronate prevents new vertebral fractures in postmenopausal women at high risk.

Authors:  Nelson B Watts; Robert G Josse; Ronald C Hamdy; Rodney A Hughes; Michael D Manhart; Ian Barton; Danny Calligeros; Dieter Felsenberg
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

Review 9.  Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.

Authors:  Lionel S Lim; Laura J Hoeksema; Kevin Sherin
Journal:  Am J Prev Med       Date:  2009-04       Impact factor: 5.043

10.  Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK.

Authors:  J Compston; A Cooper; C Cooper; R Francis; J A Kanis; D Marsh; E V McCloskey; D M Reid; P Selby; M Wilkins
Journal:  Maturitas       Date:  2009-01-08       Impact factor: 4.342

View more
  1 in total

Review 1.  Osteoporosis in men: a review.

Authors:  Robert A Adler
Journal:  Bone Res       Date:  2014-04-29       Impact factor: 13.567

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.